Addleshaw Goddard has advised DunPort Capital Management in relation to the financing of Schivo Medical’s acquisition of APN Global.

The deal sees Schivo Medical, the Waterford headquartered health device manufacturer, strengthen its presence in North America.

The acquisition, which completed on November 7th, was financed by DunPort Capital Management alongside Bank of Ireland Corporate Banking. The Addleshaw Goddard team which advised DunPort Capital Management was led by Ray Byrne (Partner, Dublin) and Alex Dumphy (Partner, London). 

Noting the significance of the acquisition, Ray Byrne, Finance Partner, Addleshaw Goddard said: "We were delighted to work with the DunPort team and congratulate them on what is an extremely significant transaction. This deal sees DunPort solidify their position as a leading provider of non-bank corporate lending in the Irish market and we look forward to continued collaboration with DunPort in the future."

Schivo Medical is the 7th company to have been supported by the Oak Corporate Credit Fund, DunPort’s €335m lending vehicle, the successor to the Elm Corporate Credit Fund. 

About Addleshaw Goddard LLP

Addleshaw Goddard LLP is a leading international law firm, with extensive experience in corporate, real estate, finance and dispute resolution. Established in 1775, Addleshaw Goddard delivers market-leading advice and strategic expertise to clients across over 100 countries via 16 offices around the globe and was named one of the top five most innovative law firms in Europe by the Financial Times (2021 and 2022).

About DunPort Capital

DunPort are the leading provider of non-bank corporate and SME debt capital in the Irish market and an emerging player in the UK lower mid market with a demonstrable track record in both. DunPort are an Irish owned asset manager, founded in 2017 by the then senior executives of BlueBay Asset Management, Pat Walsh and Ross Morrow who successfully established the first private debt platform in Ireland in 2013.